Hitesh Bhai,

You have on most of the occasions said that once the sector fancy is over, its better to look at stocks in a different sector which does show interest, than look at same sector.

If we take recent past, specialty chemicals had a great run. stocks which were 1-2 times sales went upto 10 times. Then the pharma sector. Now if we see again, some picks of chemicals sector viz., Gujarat Fluorochem, SRF, Navin Flourine seem to be coming back to fancy on back of good to solid results. How cautious you are in betting these kind of outliers which belong to sector which had its good time.

Results do look bad. The reason given for registering a 42% year-on-year decline in profit at Rs 53 crore for the quarter ended June 2022 was because of the spillover of service billing followed by non-availability of required infrastructure from the customer end and continued shortage of semiconductors. Revenue declined 13% to Rs 1,051 crore during the same period, however exports grew by 167% YoY, with strong order book worth more than Rs 5,300 crore as of June 2022. So, I will hang on for another quarter to see how’s its trending then.

Great results! Q1 profit jumps more than 4-fold to Rs 7.34 crore, total income more than doubles to Rs 123.8 crore. The company has recorded a 332% year-on-year growth in profit at Rs 7.34 crore for the quarter ended June 2022, compared to Rs 1.70 crore in same period last year. Total income jumped 141.4% to Rs 123.80 crore during the same period. Revenues and PAT up both QoQ and YoY. Has anyone noticed anything negative in the results? Thanks.

Thanks for the suggestion.
On Pharma, you are right… I will exit some if there results are bad for couple of quarters.
TechM and HCLtech - will replace with LTTS or ELXSI.
Thanks for your time…